Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | REN | P00797 | 20/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7318969 | 1.00 | REN (0.66) | REN | |
| SCHEMBL7324731 | 1.00 | REN (0.66) | REN | |
| SCHEMBL7318973 | 1.00 | REN (0.66) | REN | |
| SCHEMBL7327981 | 0.93 | REN (0.76) | REN | |
| SCHEMBL7320335 | 0.93 | REN (0.76) | REN | |
| SCHEMBL7327974 | 0.93 | REN (0.76) | REN | |
| SCHEMBL7320341 | 0.93 | REN (0.76) | REN | |
| SCHEMBL7279339 | 0.91 | REN (0.69) | REN | |
| SCHEMBL7270369 | 0.91 | REN (0.69) | REN | |
| SCHEMBL7270374 | 0.91 | REN (0.69) | REN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5364844-A | Hypotensive agents | SANKYO COMPANY, LIMITED (JP) | 1994-11-15 | — | — | US | claimed |
| EP-0326364-B1 | Renin inhibitory oligopeptides, their preparation and use | SANKYO CO (JP) | 1994-06-22 | — | — | EP | claimed |
| EP-0326364-A2 | Renin inhibitory oligopeptides, their preparation and use | Sankyo Company Limited (JP) | 1989-08-02 | — | — | EP | claimed |
| US-5364844-A | Hypotensive agents | SANKYO COMPANY, LIMITED (JP) | 1994-11-15 | — | — | US | disclosed |
| EP-0326364-A2 | Renin inhibitory oligopeptides, their preparation and use | Sankyo Company Limited (JP) | 1989-08-02 | — | — | EP | disclosed |